- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions | ||
| Di | Pfizer rebuked by FDA for misleading Adcetris ads on Facebook | ||
| 13.04. | Lilly's Jaypirca shows fixed-duration power in 'ambitious' phase 3 CLL trial win | ||
| 13.04. | ViiV launches 'Still Here' campaign aimed at reminding younger people about HIV | ||
| 10.04. | HHS, after legal setback, updates ACIP charter to put more emphasis on vaccine safety | ||
| 10.04. | Charles River flows into Boston to help AHA bridge cardiovascular health divide | ||
| 10.04. | Starting material sourcing bottlenecks increase US drug shortage risks: report | ||
| 10.04. | Novartis cuts 114 more jobs at New Jersey HQ as restructuring rolls on | ||
| 10.04. | Envision hires ConcertAI, IQVIA alum Nick Jones as its med comms president | ||
| 10.04. | The top 10 pharma R&D budgets of 2025 | ||
| 10.04. | Bial launches 'Dialogues with Parkinson's' campaign aimed at identifying early symptoms | ||
| 10.04. | Abbott survey finds 'information overload, confusion and cost' affecting health choices in US | ||
| 10.04. | FDA accuses Amneal, BioCorRx of producing 'false and misleading' drug promos | ||
| 10.04. | Novartis pumps up community health footprint to tackle heart disease and cancer | ||
| 09.04. | Vanda initiates study of motion sickness drug Nereus on GLP-1 users | ||
| 09.04. | Garda snaps up Assertio and chemo infection treatment Rolvedon in $125M deal | ||
| 09.04. | AbbVie challenges 'outdated' 340B drug discount program guidance in new lawsuit | ||
| 09.04. | RFK Jr. launching health podcast to expose 'hypocrisy' and 'corruption' | ||
| 08.04. | Steven Ubl set to depart after more than a decade as CEO of PhRMA | ||
| 08.04. | Shionogi nabs initial $119M award from BARDA to establish US antibiotic plant | ||
| 08.04. | J&J's Tremfya retakes TV drug ad spending crown from AbbVie | ||
| 08.04. | Pfizer walks away from 'underutilized' office space in South San Francisco, transitions employees to remote roles | ||
| 08.04. | Biogen settles investor lawsuit over its messaging on failed Alzheimer's drug Aduhelm | ||
| 08.04. | Amgen CEO netted $24.7M pay package in '25 as company's upward trajectory continued | ||
| 08.04. | Cognito Therapeutics moves to drop 'dementia' from its comms, scientific materials |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.